Headquartered in Dublin, Ireland Jazz Pharmaceuticals is a specialty biopharmaceuticals company that has undergone significant growth in recent years. Jazz Pharmaceuticals is focused upon delivering products for cataplexy, narcolepsy, oncology/leukemia, chronic pain and non-opioid schizophrenia.   Read the full story

Jazz Pharmaceuticals, listed as a new big biotech entrant in 2014, has announced 3 M&A deals since 2009, with the lead deals being the acquisitions of Gentium and merger with Azur Pharma. Read the full story